Literature DB >> 26440981

Biomarkers: Troponin testing--risk stratification to stratified medicine.

L Kristin Newby1, E Magnus Ohman1.   

Abstract

Among patients with diabetes mellitus and ischaemic heart disease, high-sensitivity testing effectively identified 39.3% of patients with elevated troponin levels who were at high 5-year risk of cardiovascular death, myocardial infarction, or stroke. Compared with optimal medical therapy, revascularization did not reduce ischaemic events among patients with elevated troponin levels.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26440981     DOI： 10.1038/nrcardio.2015.157

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  9 in total

1.  Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.

Authors:  Michael P Hudson; Christopher M O'Connor; Wendy A Gattis; Gudaye Tasissa; Vic Hasselblad; Cathy M Holleman; Laura H Gaulden; Frank Sedor; E Magnus Ohman
Journal:  Am Heart J       Date:  2004-03       Impact factor: 4.749

2.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

Authors:  Christopher R deFilippi; James A de Lemos; Robert H Christenson; John S Gottdiener; Willem J Kop; Min Zhan; Stephen L Seliger
Journal:  JAMA       Date:  2010-11-15       Impact factor: 56.272

3.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.

Authors:  D A Morrow; C P Cannon; N Rifai; M J Frey; R Vicari; N Lakkis; D H Robertson; D A Hille; P T DeLucca; P M DiBattiste; L A Demopoulos; W S Weintraub; E Braunwald
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

4.  Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.

Authors:  L K Newby; E M Ohman; R H Christenson; D J Moliterno; R A Harrington; H D White; P W Armstrong; F Van De Werf; M Pfisterer; V Hasselblad; R M Califf; E J Topol
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

5.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

Authors:  James A de Lemos; Mark H Drazner; Torbjorn Omland; Colby R Ayers; Amit Khera; Anand Rohatgi; Ibrahim Hashim; Jarett D Berry; Sandeep R Das; David A Morrow; Darren K McGuire
Journal:  JAMA       Date:  2010-12-08       Impact factor: 56.272

6.  Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome.

Authors:  Nicholas L Mills; Antonia M D Churchhouse; Kuan Ken Lee; Atul Anand; David Gamble; Anoop S V Shah; Elspeth Paterson; Margaret MacLeod; Catriona Graham; Simon Walker; Martin A Denvir; Keith A A Fox; David E Newby
Journal:  JAMA       Date:  2011-03-23       Impact factor: 56.272

7.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

8.  Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.

Authors:  Brendan M Everett; Maria Mori Brooks; Helen E A Vlachos; Bernard R Chaitman; Robert L Frye; Deepak L Bhatt
Journal:  N Engl J Med       Date:  2015-08-13       Impact factor: 91.245

9.  Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry).

Authors:  Thomas M Maddox; Paul S Chan; John A Spertus; Fengming Tang; Phil Jones; P Michael Ho; Steven M Bradley; Thomas T Tsai; Deepak L Bhatt; Pamela N Peterson
Journal:  J Am Coll Cardiol       Date:  2013-10-30       Impact factor: 24.094
  9 in total
  2 in total

Review 1.  Cancer as a Risk Factor for Cardiovascular Disease.

Authors:  Dana Elena Giza; Gloria Iliescu; Saamir Hassan; Konstantinos Marmagkiolis; Cezar Iliescu
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

2.  Circulating Hematopoietic Stem/Progenitor Cells are Associated with Coronary Stenoses in Patients with Coronary Heart Disease.

Authors:  Fu-Li Zhu; Ning Zhang; Xiao-Juan Ma; Jing Yang; Wei-Ping Sun; Yi-Qing Shen; Yu-Mei Wen; Sha-Sha Yuan; Dong Zhao; Hai-Bin Zhang; Ying-Mei Feng
Journal:  Sci Rep       Date:  2019-02-08       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.